According to Eurobio Scientific's latest financial reports and stock price the company's current Operating Margin is 8.67%. At the end of 2023 the company had an Operating Margin of 8.68%.
Year | Operating Margin | Change |
---|---|---|
2023 | 8.68% | -57.14% |
2022 | 20.24% | -47.7% |
2021 | 38.70% | -10.15% |
2020 | 43.07% | 2811.28% |
2019 | 1.48% | -141.84% |
2018 | -3.54% | -82.3% |
2017 | -19.98% | -23.73% |
2016 | -26.19% | 29.92% |
2015 | -20.16% | 3.25% |
2014 | -19.53% | -13.6% |
2013 | -22.60% | -81.73% |
2012 | -123.72% | -9.68% |
2011 | -136.98% | 65.34% |
2010 | -82.85% | -58.05% |
2009 | -197.47% | -26.89% |
2008 | -270.09% | 86.61% |
2007 | -144.74% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.